TABLE 1

Hemodynamic Parameters: Isolated Rat Heart Experiments

Time after 99mTcN-NOET injection (min)
Baseline015304560
LVESP (mm Hg)
 Control (no BSA)100.0 ± 4.6103.1 ± 4.2104.3 ± 4.8102.1 ± 5.096.0 ± 3.397.6 ± 3.2
 FA-free BSA99.3 ± 7.493.5 ± 3.494.8 ± 4.098.2 ± 2.391.9 ± 1.494.8 ± 3.3
 BSA107.9 ± 5.8104.5 ± 6.2107.0 ± 6.699.1 ± 6.199.0 ± 4.2100.2 ± 3.9
LVEDP (mm Hg)
 Control (no BSA)4.5 ± 0.24.3 ± 0.33.5 ± 0.34.0 ± 0.33.2 ± 0.33.1 ± 0.3
 FA-free BSA3.8 ± 0.24.0 ± 0.44.8 ± 0.65.2 ± 0.55.2 ± 0.2*5.0 ± 0.5
 BSA5.3 ± 0.34.3 ± 0.24.5 ± 0.24.2 ± 0.44.3 ± 0.55.0 ± 0.5
CPP (mm Hg)
 Control (no BSA)35.0 ± 1.933.6 ± 1.435.2 ± 1.636.3 ± 2.135.3 ± 1.837.3 ± 1.6
 FA-free BSA32.4 ± 2.033.2 ± 2.733.3 ± 1.835.1 ± 1.935.9 ± 1.636.3 ± 1.7
 BSA37.2 ± 2.434.5 ± 2.637.2 ± 2.536.0 ± 2.536.3 ± 1.738.0 ± 2.0
dP/dtmax (mm Hg/s)
 Control (no BSA)4,507 ± 4034,506 ± 4624,480 ± 4024,660 ± 3524,484 ± 2054,676 ± 483
 FA-free BSA4,209 ± 3843,667 ± 5603,612 ± 2144,164 ± 3674,207 ± 1013,882 ± 236
 BSA4,547 ± 5574,526 ± 3034,900 ± 5384,542 ± 3344,567 ± 6044,288 ± 348
  • * P < 0.05 vs. baseline.

  • P < 0.05 vs. control (no BSA).

  • LVESP = left ventricular end-systolic pressure; LVEDP = left ventricular end-diastolic pressure; CPP = coronary perfusion pressure; dP/dt = peak positive first derivative of left ventricular pressure with respect to time.